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Summary
Objective: To compare serum levels of hyaluronic acid (HA) between patients with erosive and non-erosive hand osteoarthritis (HOA), and
investigate its association with morphological changes and radiographic progression over 2 years.
Methods: Fifty-ﬁve women with erosive and 33 women with non-erosive HOA were included in this study. All underwent clinical examination,
which included assessment of pain, swelling, deformity and deviation of small hand joints and completed health assessment questionnaires.
Serum levels of HA were measured by ELISA. Three-phase bone scintigraphy was performed at baseline. Radiographs of both hands were
performed at baseline and after 2 years and scored according Kallman grading scale.
Results: Serum levels of HA were signiﬁcantly higher in patients with erosive than with non-erosive HOA (P< 0.01). It correlated signiﬁcantly
with the number of hand joints with deviations and deformities. HA adjusted for age and disease duration signiﬁcantly correlated with radio-
graphs at baseline and after 2 years in all patients with HOA (r¼ 0.560 and r¼ 0.542, P< 0.01 for both correlations). Although there was an
association between HA and radiographic score in erosive disease, after adjustment for confounders it remained no longer signiﬁcant. HA
adjusted for confounders correlated signiﬁcantly with the late phase in all patients with HOA (r¼ 0.412, P< 0.01) and in patients with erosive
disease (r¼ 0.320, P< 0.05).
Conclusion: HA is increased in patients with erosive HOA and could be proposed as a surrogate marker with a predictive value for further
radiographic progression of HOA in general. Further investigation is necessary to conﬁrm these results.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Erosive osteoarthritis (OA) is a subset of handOA (HOA)with
prominent local inﬂammation of hand joints deﬁned radio-
graphically by subchondral erosion, cortical destruction and
subsequent reparative change1. There is a strong familiar
predisposition andmost typically middle-aged women are af-
fected. OA is commonly classiﬁed as a ‘‘non-inﬂammatory’’
arthropathy, however, serum C-reactive protein (CRP) has
been found to be moderately increased compared to healthy
population and has been proposed as a marker of disease
severity in patients with OA of the hips and knees2,3. Al-
though systemic levels of CRPmay be increased by synovial
inﬂammation, conclusive evidence that CRP corresponds to
the activity of the erosive disease is still missing4e7.
The diagnosis of OA is generally based on clinical and ra-
diographic ﬁndings, which occur fairly late and are insufﬁcient
for the prediction of disease progression. Biological markers
of the degradation, synthesis or inﬂammation that play key
functional roles in the joint tissue, might help to detect OA
atmuch earlier stages than the imaging techniques or identify
patients at high risk of rapidly progressive joint destruction8,9.*Address correspondence and reprint requests to: Dr Ladislav
Sˇenolt, Institute of Rheumatology, Na Slupi 4, Prague 2, 128 50,
Czech Republic. Tel: 420-234-075-232; Fax: 420-224-914-451;
E-mail: seno@revma.cz
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1615Hyaluronic acid (HA) is crucial for the structural and func-
tional integrity of articular cartilage and responsible for
unique viscoelastic properties of the synovial ﬂuid10,11. It
is generally considered as a marker of synovitis. Higher
levels of HA in synovial ﬂuid in comparison with serum
were reported in patients with rheumatoid arthritis (RA)
and OA, suggesting its local production12. Moreover, serum
HA levels were shown to be elevated in patients with
OA9,12e14 and demonstrated as a possible predictive factor
for further development of OA of the knees and hips13,15,16.
The aim of the study was to compare serum levels of HA
between patients with erosive and non-erosive HOA, and
investigate its potential association with morphological
changes and radiographic progression over 2 years.
MethodsPATIENTSEighty-eight women between the ages of 52 and 72 years presenting with
HOA were recruited into this study from the out-patient Rheumatology Clinic.
All the patients fulﬁlled the American College of Rheumatology (ACR) criteria
for HOA17 and patients with erosive HOA fulﬁlled those criteria and had ra-
diographic signs of erosions of the articular surface (Supplementary mate-
rial). One single erosion of proximal or distal interphalangeal joint was
sufﬁcient to consider the disease erosive. We extended the group of patients
with HOA that had been studied in our previous work18. Patient’s character-
istics at the study entry are given in Table I. Written informed consent from
each patient was obtained prior to enrollment and the study was approved
by the local ethic committee.
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uate HOA pain, stiffness and difﬁculties with daily activities during the pre-
ceding 48 h, Australian Canadian OA hand index (AUSCAN) was
performed19. The functional index for HOA (FIHOA), a 10-item investiga-
tor-administered questionnaire, was evaluated20. Clinical examination was
performed by skilled rheumatologists. Positive hand joints for swelling,
pain, deformity and deviation were evaluated by clinical examination at base-
line. The deformity included both Heberden and Bouchard nodes. The devi-
ation was assessed as any difference between the normal, natural axis of the
joint and the actual direction of a ﬁnger either ulnar or radial.IMAGE ANALYSISPostero-anterior plain radiographs of both hands were performed at base-
line and after 2 years of follow-up and were scored by trained reader accord-
ing to Kallman grading scale21. Individual joints were assessed for the
presence of osteophytes (graded 0e3), joint space narrowing (0e3), sub-
chondral sclerosis (0e1), subchondral cysts (0e1), lateral deformity (0e1),
and collapse of central joint cortical bone (0e1). For radiographic imaging
of the knees, a technique with knee in extension was used as described ear-
lier22 and scored according to the Kellgren and Lawrence (KeL) grading sys-
tem, Steinbrocker’s modiﬁcation23.
Ultrasonography of both knees was performed by an experienced radiol-
ogist at baseline. For the purpose of this study, presence or absence of knee
joint effusion and/or synovial edema was evaluated.
Three-phase bone scintigraphy was performed following a bolus injection
of 600 MBq of Tc-99m methylene disphosphonate (MDP) into an antecubital
vein. Blood pool (second phase) images were obtained after 10 min; late
(third phase) images were acquired after 2.5 h after 99Tc-MDP application.
All the planar anterior images focused on small hand joints were interpreted
by the same radiologist. Following regions of joints of the hand were deter-
mined: proximal and distal interphalangeal, metacarpophalangeal, carpome-
tacarpal, intercarpal and radiocarpal joints of both hands. Hand joints were
considered inﬂamed when blood pool images indicated increased indicator
uptake. Osteoblastic activity presenting bone remodeling was established
by increased indicator uptake in the late phase. For the purpose of this study,
total number of positive joints was calculated.LABORATORY MEASUREMENTSTable II
Clinical assessment of small hand joints in women with erosive and
non-erosive HOA
Feature Erosive HOA Non-erosive
HOA
P
Physical investigation (mean count of jointsSD)Peripheral blood was withdrawn at baseline from all patients. Collected
blood serum was stored at 80C until all the samples were analyzed. CRP
levelswere determined by the immuno-turbidimetric technique (high sensitivity
CRP) using biochemical analyzer Olympus (model AU 400, Japan). HA serum
levels were measured by commercially available ELISA assays according to
the manufacturer’s protocol (Corgenix HA Test kit, Corgenix Inc., USA). The
absorbance was measured at 450 nm by Enzyme-Linked ImmunoSorbent
Assay (ELISA) reader (Tecan Sunrise, Austria). Normal range of HA provided
in the ELISA kit is 0e75 ng/ml.Deformity 10.53 4.37 8.22 4.43 0.019
Deviation 4.05 2.85 1.56 2.03 0.001
Pain 8.33 4.12 5.53 3.93 0.004STATISTICAL ANALYSIS




Baseline 42/55 26/33 NA
After 2 years 31/55 22/33 NA
Kallman scoreData were expressed as means and standard deviation (SD) or standard
error of the mean (S.E.M.). The Mann Whitney U test was used for the compar-
ison between two variables. P values less than 0.05 were considered statisti-
cally signiﬁcant. Spearman’s correlation coefﬁcient was used to determine the
statistical signiﬁcance. Pearson correlation coefﬁcient was used after the ad-
justment ofHA levels for confounders (age anddiseaseduration). Theanalysis
was performed using SPSS 13.0 for Windows and the graphs were created by
GraphPad Prism 5 (version 5.02; GraphPad Software, La Jolla, CA, USA).Table I
Initial characteristic of women with erosive and non-erosive HOA
Characteristics Erosive HOA Non-erosive HOA P
Age (years) 64.20 8.05 62.55 9.81 0.572
Sex (F/M) 55/0 33/0 NA
BMI (kg/m2) 26.83 3.67 26.31 4.78 0.538
Disease duration
(years)
10.20 8.61 7.30 5.37 0.207
AUSCAN (15e75) 41.15 10.86 33.27 9.72 0.001
FIHOA (10e40) 18.07 4.56 15.36 4.33 0.001
SYSADOA (%) 78.18 66.67 0.239
NSAID (%) 20.00 6.06 0.045
hs-CRP (mg/l) 1.93 1.68 2.77 6.09 0.599
ESR 14.74 10.33 15.08 10.10 0.808
NA, not applicable. Values are in meansSD.ResultsCLINICAL AND DEMOGRAPHIC DATAFemale patients with HOA were divided into two groups
that consisted of 33 individuals with non-erosive HOA and
55 individuals with erosive disease. Both groups were com-
parable in terms of age, disease duration and body mass in-
dex (BMI). Moreover, inﬂammatory marker hs-CRP and
erythrocyte sedimentation rate (ESR) were comparable be-
tween both groups (Table I). Patients with erosive HOA
seem to suffer with more pain, stiffness and restriction in
daily activities as assessed by both total AUSCAN score
and FIHOA index and more of them were on regular treat-
ment with non-steroidal anti-inﬂammatory drugs (NSAIDs)
compared to patients with non-erosive HOA (Table I). Treat-
ment with symptomatic slow acting drugs in OA (SYSA-
DOA) did not differ between the studied groups. Clinical
investigation of the hand joints showed more severe course
of the disease in erosive HOA patients manifested by signif-
icantly higher number of joints with effusion, pain, deviation
and deformity (Table II).
Out of 55 patients with erosive HOA, 42 radiographs were
scored according Kallman grading scale at baseline and 31
were available after 2 years of follow-up. Out of 33 patients
with non-erosive HOA, 26 hand radiographs were scored
according Kallman grading scale at baseline and 22 were
available after 2 years of follow-up. Patients with erosive
HOA exhibited 1e19 erosions (meanSD: 8.18 4.89;
Table II). As expected, patients with erosive HOA compared
to non-erosive HOA had more severely affected hand joints
at baseline and after 2 years. The mean radiographic(mean SD)
Baseline 58.30 28.1 26.56 18.28 0.001
After 2 years 60.97 27.86 26.26 18.44 0.001
D (progression) 2.41 3.06 0.57 1.07 0.002
Erosions (numberSD) 8.18 4.89 0 0.001
OA of the knee
(present/all)
27/53 18/31 0.530








Number of scintigrams 52/55 29/33 NA
Count of inﬂamed
joints (mean SD)
3.06 2.26 1.82 3.02 0.001
Count of remodeled
joints (mean SD)
8.60 4.74 4.07 4.28 0.001
1617Osteoarthritis and Cartilage Vol. 17, No. 12progression (D Kallman score) within 2 years was four times
faster in erosive than in non-erosive disease (Table II).
Knee radiographs were available in 53 out of 55 patients
from the group of erosive HOA patients and in 31 out of
33 patients from the group with non-erosive HOA. Preva-
lence of OA of the knee between both groups was compa-
rable (Table II). Arthrosonography of the knee was available
in 54 out of 55 patients from the group of erosive HOA and
in 32 out of 33 patients from non-erosive HOA. Presence of
synovial edema and intra-articular effusion of the knees
also did not differ between studied groups (Table II).
Three-phase bone scintigraphy was performed at baseline
in 52 out of 55 patients with erosive HOA and in 29 out of
33 patients with non-erosive HOA. The total count of joints
of the hand affected by inﬂammation and bone remodeling
as assessed by blood pool and late phase scintigraphy, re-
spectively, was signiﬁcantly higher in patients with erosive
compared to non-erosive HOA (Table II).HA AND STRUCTURAL CHANGES IN HOAHA signiﬁcantly correlated with both age (r¼ 0.448,
P< 0.01) as well as disease duration (r¼ 0.333,
P< 0.01), but not with BMI (r¼ 0.195, P¼ 0.09) or treat-
ment with NSAIDs (r¼0.074, P¼ 0.580) in all patients
with HOA. Serum levels of HA were signiﬁcantly higher in
patients with erosive than in non-erosive HOA
[78.53 51.31 vs 50.45 41.25 ng/ml, P< 0.01; Fig. 1(A)]
and this ﬁnding remained signiﬁcant also after adjustment
for age and disease duration [78.53 23.59 vs
50.45 22.72 ng/ml, P< 0.01; Fig. 1(B)]. In all HOA pa-
tients, HA levels signiﬁcantly correlated with the number
of positive hand joints for clinically assessed deviations
and deformities (r¼ 0.397 and r¼ 0.399, P< 0.01 for both
correlations). These results remained statistically signiﬁcant
only in the group of patients with erosive disease (r¼ 0.318,
P< 0.01 for deviations and r¼ 0.382, P< 0.01 for defor-
mities), but not in patients with non-erosive HOA
(r¼ 0.340, P¼ 0.066 for deviations and r¼ 0.294,
P¼ 0.115 for deformities). On the other hand, HA levels
correlated neither with clinically assessed hand joint swell-
ing nor pain (data not shown). Serum levels of HA were
not affected by the presence of knee joint effusion or syno-
vial edema as assessed by arthrosonography in patients
with erosive as well as non-erosive HOA (data not shown).
Serum HA levels signiﬁcantly correlated with the total
count of joints with osteoblastic remodeling as assessed
by late phase scintigraphy (r¼ 0.291, P< 0.01) in allFig. 1. Increased serum levels of HA in patients with erosive HOA compare
and disease duration. Horizontal solid bar within the boxes represents th
Vertical bars indicate 95% copatients with HOA, but not with the total count of inﬂamed
joints as assessed by blood pool phase. This signiﬁcant as-
sociation was demonstrated for both groups together but
not for each group separately. After adjustment for age
and disease duration, the abovementioned ﬁnding re-
mained signiﬁcant in all patients with HOA (r¼ 0.412,
P< 0.01) and became signiﬁcant in patients with erosive
disease (r¼ 0.320, P¼ 0.05) but not in those with non-ero-
sive disease (r¼ 0.094, P¼ 0.637). Furthermore, HA levels
signiﬁcantly correlated with radiographic ﬁndings assessed
by Kallman radiographic score at baseline in erosive and
non-erosive HOA patients (r¼ 0.402, P< 0.05 and
r¼ 0.597, P< 0.01, respectively). After 2 years it also corre-
lated signiﬁcantly with the radiographic ﬁndings in patients
with both erosive HOA (r¼ 0.391, P< 0.05) and non-ero-
sive HOA (r¼ 0.634, P< 0.01). However, after adjustment
for age and disease duration, the correlation remained sta-
tistically signiﬁcant in the group of patients with non-erosive
disease at both time points (r¼ 0.416, P< 0.05 at the base-
line; r¼ 0.505, P< 0.05 after 2 years) but remained no lon-
ger signiﬁcant in erosive HOA patients (r¼ 0.287, P¼ 0.10
at the baseline; r¼ 0.334, P¼ 0.10 after 2 years). The cor-
relation between HA and Kallman score in all HOA patients
was signiﬁcant at the beginning and after 2 years of follow-
up (r¼ 0.518, P< 0.01; r¼ 0.519, P< 0.01, respectively)
and this ﬁndings remained signiﬁcant also after adjustment
for age and disease duration (r¼ 0.560, P< 0.01 and
r¼ 0.542, P< 0.01; Fig. 2).
Interestingly, CRP was neither elevated in patients with
erosive compared to non-erosive HOA nor was associated
with scintigraphic assessment of the total count of positive
hand joints or radiographic ﬁndings in both groups of HOA
patients (data not shown).
Discussion
In this study, we demonstrated for the ﬁrst time higher se-
rum levels of HA in patients with erosive than in non-erosive
HOA. In addition, HA was associated with the local morpho-
logical and structural changes as well as with the further ra-
diographic progression of the disease.
Pain, swelling, redness, warmth and restricted function of
small joints of the hand represent the most characteristic
clinical symptoms for the most patients with erosive
HOA24. Our clinical assessment could conﬁrm more severe
disease course in patients with erosive than non-erosive
HOA. This impairment resulted in the signiﬁcant limitation
of daily activities in patients with erosive than in non-erosived with non-erosive HOA without (A) and with (B) adjustment for age
e median, the boxes represent a range of 25% around the median.
nﬁdential interval (CI).
Fig. 2. Association of serum levels of HA adjusted for age and disease duration with Kallman radiographic score of small hand joints at the
beginning (A) and after 2 years (B) of the study in the patients with HOA.
1618 M. Filkova´ et al.: Hyaluronic acid in hand osteoarthritisHOA as revealed by total AUSCAN score and FIHOA that is
in line with another recent study25.
Few studies have investigated biochemicalmarkers in ero-
siveHOApatients. Punzi et al.6 reported higher levels ofCRP
in erosive than in non-erosive HOA patients and proposed
CRP as a marker of disease activity of erosive HOA as as-
sessed by clinical ﬁndings and bone scintigraphy. Contrary,
lower systemic inﬂammatory markers in erosive compared
to non-erosive disease have also been previously de-
scribed5. In the present study, we observed no differences
in the serum CRP levels between erosive and non-erosive
HOA despite the fact that bone scintigraphy revealed signiﬁ-
cantly more affected small hand joints in erosive disease.We
suggest that local inﬂammatory changes might not be as in-
tensive to induce systemic inﬂammatory response in patients
with HOA, at least in our study.
In normal joint, functional and metabolic activities of HA
depend on its high concentration and high molecular
weight26. During inﬂammation, reactive free radicals from
neutrophiles in synovial ﬂuid damage and depolymerizate
HA that leads to reduction of its high molecular weight27e29.
It contributes to reduction in synovial ﬂuid viscosity and to
dialysis of HA fragments and disaccharide monomers into
the circulation30,31. Soluble pro-inﬂammatory cytokines in-
cluding interleukin (IL)-1 and tumor necrosis factor (TNF)-
a can also be responsible for the synovial production of
HA32. Small HA oligosaccharides in the joint antagonize
with high molecular mass HA, interfere with the normal
chondrocyteematrix interactions33,34, activate production
and activity of matrix metalloproteinases, nitric oxide syn-
thesis by articular chondrocytes and inﬂammatory
cells35e37. This process is involved in OA pathogenesis
and it can be suggested that increased serum levels of
HA in patients with erosive HOA can reﬂect synovial inﬂam-
mation and destruction of OA cartilage in erosive disease.
Moreover, very recently, Chen et al.38 demonstrated in-
creased HA in OA patients associated with clinical pheno-
types of HOA or hand symptoms in comparison to those
without involvement of hand joints. In fact, there is still
lack of studies analyzing biomarkers in erosive and non-
erosive HOA39, and to our knowledge, our study is the ﬁrst
report presenting higher levels of serum HA in patients with
erosive compared with non-erosive HOA.
Bone scintigraphy was suggested to be useful tool for
predicting clinical and radiographic progression in patients
with HOA5. In the present study, serum HA levels correlated
with the total count of small hand joints positive in bone
phase scintigraphy and one can thus speculate that thisﬁnding could explain the association of HA with small
hand joint morphological changes that were observed.
Moreover, age and disease duration seems to affect this re-
sult, because after adjustment for these confounders the
ﬁnding became more signiﬁcant even in patients with ero-
sive HOA. More interestingly, initial HA levels were signiﬁ-
cantly associated with the degree of radiographic changes
at baseline and also after 2 years of follow-up. These
data are in agreement with previous studies demonstrating
HA as a surrogate marker with the predictive value for fur-
ther radiographic progression of the knee and hip
OA15,16,40,41. In our study, HA levels were positively associ-
ated with the age and duration of the disease. When ad-
justed for these confounders, positive relationship
between HA and radiographic ﬁndings remained un-
changed in all patients with HOA, but was no longer signif-
icant in patients with erosive disease.
However, this study has some limitations. First, OA is often
generalized disease and HA serum levels may be elevated
due to the contribution of other joints. For this speciﬁc reason,
wehaveperformed radiographic imagingandultrasonography
of the knees toexamine theprevalenceof kneeOA, effusionor
synovial edema. Both studied groups were comparable in
terms of these variables. However, we cannot exclude contri-
bution of other joints such as particularly hips or spine, but we
were not allowed to assess these joints by radiography due to
ethical reasons. Second, HA levels were analyzed only at the
beginning and were not available after 2 years of the study.
Similarly, we were able to examine less patients by hand radi-
ography after the 2 year follow-up due to loss of some patients
mostly due to patient’s decision. Thereby, some of our data
may remain insigniﬁcant. Third, this study does not have
healthy controls included. We believe it is unethical to assess
radiography of several joint regions in otherwise healthy indi-
viduals that may nevertheless, if older than 60 years, suffer
from subclinical OA.
In summary, this is the ﬁrst study showing higher serum
levels of HA in patients with erosive compared with non-ero-
sive HOA and demonstrating its association with local mor-
phological and structural changes. We suggest serum HA
as a potential surrogate marker with a predictive value for
further radiographic progression of HOA. Further studies
are necessary to conﬁrm these results.
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